CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, CHINA – China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product...

The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products

Nationwide Expansion of Product Selection, Customer Support, and Online Shopping Experience Reinforces The Pool Factory’s Standing as America’s Above Ground Pool Experts EDISON, N.J., Jun 23, 2026, ZEX PR WIRE — The Pool Factory, one of the nation’s...